Merck Sharp & Dohme

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

IBM’s planned acquisition of HRL Laboratories could strengthen its quantum computing roadmap by adding silicon-spin qubit technology and expanding its advanced semiconductor research capabilities. Representative image.

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

Pfizer, Astellas Pharma and Merck secure expanded U.S. FDA approval for Padcev plus Keytruda in muscle-invasive bladder cancer treatment. Representative image.

Pfizer (PFE), Merck (MRK) win FDA expansion for Padcev plus Keytruda in all MIBC patients

Pfizer (PFE) Padcev+Keytruda MIBC label expands to all patients as first platinum-free regimen; AstraZeneca's Imfinzi cisplatin-only slot loses ground.

byVenkatesh

July 12, 2026

Can Ampligen improve immunotherapy durability in recurrent ovarian cancer treatment?

Can AIM ImmunoTech Inc.’s Ampligen improve immunotherapy durability in ovarian cancer? Explore the Phase 2 data and industry impact.

bySoujanya Ravi

May 9, 2026

The Latest

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

Pfizer (PFE), Merck (MRK) win FDA expansion for Padcev plus Keytruda in all MIBC patients

Can Ampligen improve immunotherapy durability in recurrent ovarian cancer treatment?

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

WSP Global raises Arcadis takeover offer to €51.50 as engineering consolidation accelerates

Wall Street welcomes Repligen’s $1.5bn BioLife deal, but integration now matters

Popular’s CEO is retiring after 14 months. Why investors should watch the CFO taking over

Renishaw plc (LSE: RSW) beats upgraded guidance with £815m full-year revenue